Werkgroep Cardiologische centra Nederland

TRUE AHF (Completed)

Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering from Acute Decompensated Heart Failure
Medicine
Urodilatin (Ularitide)
Population
Heart failure
Phase
III
Starting year
2012
More information
ClinicalTrials.gov

Director of Study

drs. F.R. den Hartog (Cardioloog)
Ede, Gelderse Vallei Ziekenhuis

Publications: TRUE AHF

  • Effect of Ularitide on Cardiovascular Mortality in Acute Heart FailureNew England Journal of Medicine - TRUE AHF - Heart failure
  • Short- and Long-Term Effect of Immediate Vasodilator Therapy in Acutely Decompensated Heart Failure: Results of the TRUE-AHF TrialAHA 2016 - TRUE AHF - Heart failure

Publications by WCN study

Publications WCN studies by WCN member